Bordetella pertussis toxin Antibodies

Santa Cruz Biotechnology offers a broad range of Bordetella pertussis toxin monoclonal antibodies for research focused on understanding the mechanisms of this critical virulence factor. Bordetella pertussis toxin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bordetella pertussis toxin is a key component of the pathogenicity of Bordetella pertussis, the bacterium responsible for whooping cough. The toxin disrupts host immune responses and facilitates bacterial colonization in the respiratory tract. Understanding Bordetella pertussis toxin function is essential for developing effective vaccines and therapeutic strategies against whooping cough. Research utilizing Bordetella pertussis toxin monoclonal antibodies has revealed significant insights into bacterial colonization mechanisms. Advanced detection methods have enabled detailed mapping of toxin distribution within host tissues. Ongoing studies continue to uncover new aspects of host-pathogen interactions. Santa Cruz Biotechnology monoclonal antibodies for Bordetella pertussis toxin research support scientists worldwide in their mission to combat infectious diseases.